European Surgery

, Volume 48, Issue 2, pp 74–91 | Cite as

Laryngopharyngeal reflux: diagnosis, treatment and latest research

Review
First Online:
Received:
Accepted:

Summary

Aim

A review of the recent changes in understanding of laryngopharyngeal and extra-oesophageal reflux symptoms.

Method

Literature search over 7 years (2008–2015) and relevant historical cited articles.

Results

Modern investigation more clearly shows a subgroup of patients with intermittent full column oesophago-gastric-reflux-causing symptoms. Multiple other sites in the lung, head and neck may also be implicated in the reflux disease process.

Conclusion

Understanding of extra-oesophageal reflux symptomology is evolving. New equipment and techniques suggest further areas of research, and as yet effective therapy remains elusive for some.

Keywords

Laryngopharyngeal reflux Gastro-oesophageal reflux Laparoscopic fundoplication 
This is a preview of subscription content, log in to check access.

Notes

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1.
    Perry KA, Pham TH, Spechler SJ, Hunter JG, Melvin WS, Velanovich V. 2014 SSAT State-of-the-Art Conference: advances in diagnosis and management of Gastroesophageal Reflux Disease. J Gastrointest Surg. 2015;19(3):458–66. http://link.springer.com/10.1007/s11605-014-2724-9.PubMedCrossRefGoogle Scholar
  2. 2.
    Wong R. ENT manifestations of gastroesophageal reflux. Am J Gastroenterol. 2000;95(1):S15–22. http://linkinghub.elsevier.com/retrieve/pii/S0002927000010741.PubMedCrossRefGoogle Scholar
  3. 3.
    Vaezi MF. Extraesophageal Reflux. San Diego: Plural Publishing; 2009.Google Scholar
  4. 4.
    Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900–20, quiz 1943. http://www.ncbi.nlm.nih.gov/pubmed/16928254 [cited 2014 Mar 26].PubMedCrossRefGoogle Scholar
  5. 5.
    Gastroenterological Society of Australia. Gastro-oesophageal reflux disease in adults. 5. Edn. Mulgrave: Digestive Health Foundation; 2011.Google Scholar
  6. 6.
    Mittal RK, Holloway RH, Penagini R, Blakshaw LA, Dent J. Transient lower esophageal relaxation. Gastroenterology. 1995;109:601–10.PubMedCrossRefGoogle Scholar
  7. 7.
    Kahrilas P, Dodds W, Hogan W. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterology. 1988;94:73–80. http://ukpmc.ac.uk/abstract/MED/3335301 [cited 2013 Jan 8].PubMedGoogle Scholar
  8. 8.
    Patti MG, Goldberg HI, Arcerito M, Bortolasi L, Tong J, Way LW. Hiatal hernia size affects lower esophageal sphincter function, esophageal acid exposure, and the degree of mucosal injury. Am J Surg. 1996;171(1):182–6. http://www.ncbi.nlm.nih.gov/pubmed/8554137.PubMedCrossRefGoogle Scholar
  9. 9.
    Weijenborg PW, Smout AJPM, Verseijden C, van Veen HA, Verheij J, de Jonge WJ, et al. Hypersensitivity to acid is associated with impaired esophageal mucosal integrity in patients with gastroesophageal reflux disease with and without esophagitis. AJP Gastrointest Liver Physiol. 2014;307(3):G323–9. http://ajpgi.physiology.org/cgi/doi/10.1152/ajpgi.00345.2013.CrossRefGoogle Scholar
  10. 10.
    Björkman EVC, Edebo A, Oltean M, Casselbrant A. Esophageal barrier function and tight junction expression in healthy subjects and patients with gastroesophageal reflux disease: functionality of esophageal mucosa exposed to bile salt and trypsin in vitro. Scand J Gastroenterol. 2013;48(10):1118–26. http://www.tandfonline.com/doi/full/10.3109/00365521.2013.828772.PubMedCrossRefGoogle Scholar
  11. 11.
    Mönkemüller K, Wex T, Kuester D, Fry LC, Kandulski A, Kropf S, et al. Role of tight junction proteins in gastroesophageal reflux disease. BMC Gastroenterol. 2012;12(1):128. http://www.biomedcentral.com/1471-230X/12/128.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Hyun JJ, Bak Y-T. Clinical Significance of Hiatal Hernia. Gut Liver. 2011;5(3):267–77.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Sloan S, Rademaker AW, Kahrilas PJ. Determinants of Gastroesophageal Junction Incompetence: hiatal Hernia, Lower Esophageal Sphincter, or Both? Ann Intern Med 1992;117(12):977. http://annals.org/article.aspx?doi=10.7326/0003-4819-117-12-977.PubMedCrossRefGoogle Scholar
  14. 14.
    Kahrilas PJ, Lin S, Chen J, Manka M. The effect of hiatus hernia on gastro-oesophageal junction pressure. Gut. 1999;44(4):476–82.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Behar J, Sheahan D. Histologic abnormalities in reflux esophagitis. Arch Pathol. 1975;99(7):387–91.PubMedGoogle Scholar
  16. 16.
    Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825–31.PubMedCrossRefGoogle Scholar
  17. 17.
    Poh CH, Gasiorowska A, Navarro-Rodriguez T, Willis MR, Hargadon D, Noelck N, et al. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment. Gastrointest Endosc. 2010;71(1):28–34. http://linkinghub.elsevier.com/retrieve/pii/S0016510709024249.PubMedCrossRefGoogle Scholar
  18. 18.
    Dent J, Vakil N, Jones R, Bytzer P, Schöning U, Halling K, et al. Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut. 2010 [cited 2013 Nov 6];59(6):714–21. http://www.ncbi.nlm.nih.gov/pubmed/20551454.PubMedCrossRefGoogle Scholar
  19. 19.
    Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. Nature Publishing Group; 2013;108(3):308–28, quiz 329. http://www.ncbi.nlm.nih.gov/pubmed/23419381. Accessed 2013 May 22PubMedCrossRefGoogle Scholar
  20. 20.
    Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993;104(2):510–3.PubMedGoogle Scholar
  21. 21.
    Di Pietro M, Fitzgerald RC. Screening and risk stratification for Barrett’s Esophagus. How to limit the clinical impact of the increasing incidence of Esophageal Adenocarcinoma. Gastroenterol Clin North Am. 2013;42(1):155–73.PubMedCrossRefGoogle Scholar
  22. 22.
    Haidry RJ, Dunn JM, Butt MA, Burnell M, Gupta A, Green S, et al. Radiofrequency Ablation (Rfa) And Endoscopic Mucosal Resection For Dysplastic Barrett’s Esophagus And Early Esophageal Adenocarcinoma: Outcomes Of Uk National Halo Rfa Registry. Gastroenterology. AGA Institute American Gastroenterological Association; 2013;(April):3447. http://www.ncbi.nlm.nih.gov/pubmed/23542069. Accessed 2013 Apr 4
  23. 23.
    Shaheen N, Sharma P, Overholt B, Radiofrequency ablation in Barrett’s esophagus with dysplasia. Engl J. 2009;360(22):2277–88. http://www.nejm.org/doi/full/10.1056/NEJMoa0808145. Accessed 2012 Jul 12
  24. 24.
    Fleischer DE, Odze R, Overholt BF, Carroll J, Chang KJ, Das A, et al. The case for Endoscopic treatment of non-dysplastic and low-grade Dysplastic Barrett’s Esophagus. Dig Dis Sci. 2010;55(7):1918–31. http://www.ncbi.nlm.nih.gov/pubmed/20405211. Accessed 2012 Jul 12PubMedCrossRefGoogle Scholar
  25. 25.
    Kristo I, Schoppmann SF, Riegler M, Püspök A, Emmanuel K, Spaun G, et al. Austrian expert panel recommendation for radiofrequency ablation of Barrett’s esophagus. Eur Surg. 2015;47(6):319–23. http://link.springer.com/10.1007/s10353-015-0362-4.CrossRefGoogle Scholar
  26. 26.
    Evans JA, Early DS, Fukami N, Ben-Menachem T, Chandrasekhara V, Chathadi KV, et al. The role of endoscopy in Barrett’s esophagus and other premalignant conditions of the esophagus. Gastrointest Endosc 2012;76(6):1087–94. http://linkinghub.elsevier.com/retrieve/pii/S0016510712025746.
  27. 27.
    National Institute for Health and Care Excellence. Endoscopic radiofrequency ablation for Barrett ’ s oesophagus with low-grade dysplasia or no dysplasia 2014. www.guidance.nice.org.uk/ipg496.
  28. 28.
    Johnson L, Demeester T. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974;62:325–32. http://europepmc.org/abstract/med/4432845. Accessed 2015 Mar 20PubMedGoogle Scholar
  29. 29.
    Mainie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut. 2006;55(10):1398–402.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Gyawali CP. High resolution manometry: the ray clouse legacy. Neurogastroenterol Motil. 2012;24(SUPPL 1):2–4.PubMedCrossRefGoogle Scholar
  31. 31.
    Pandolfino JE, Richter JE, Ours T, Guardino JM, Chapman J, Kahrilas PJ. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol. 2003;98(4):740–9. http://www.ncbi.nlm.nih.gov/pubmed/12738450.
  32. 32.
    Lundell LR, Dent J, Bennett JR, Blum a L, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45(2):172–80.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Sifrim D, Zerbib F. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut. 2012;61(9):1340–54. http://www.ncbi.nlm.nih.gov/pubmed/22684483. Acessed 2013 Feb 4PubMedCrossRefGoogle Scholar
  34. 34.
    Labenz J, Armstrong D, Lauritsen K, Katelaris P, Schmidt S, Schütze K, et al. A randomized comparative study of esomeprazole 40 mg versus pantoprazole 40 mg for healing erosive oesophagitis: the EXPO study. Aliment Pharmacol Ther. 2005;21(6):739–46. http://www.ncbi.nlm.nih.gov/pubmed/15771760.PubMedCrossRefGoogle Scholar
  35. 35.
    Castell DO, Kahrilas PJ, Richter JE, Vakil NB, Johnson DA, Zuckerman S, et al. Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. Am J Gastroenterol. 2002;97(3):575–83. http://www.ncbi.nlm.nih.gov/pubmed/11922549\n http://www.nature.com/ajg/journal/v97/n3/pdf/ajg2002150a.pdf.PubMedCrossRefGoogle Scholar
  36. 36.
    Zerbib F, Sifrim D, Tutuian R, Attwood S, Lundell L. Modern medical and surgical management of difficult-to-treat GORD., United Eur Gastroenterol J. 2013;1(1):21–31. http://ueg.sagepub.com/lookup/doi/10.1177/2050640612473964.CrossRefGoogle Scholar
  37. 37.
    Shah NH, LePendu P, Bauer-Mehren A, Ghebremariam YT, Iyer SV, Marcus J, et al. Proton pump inhibitor usage and the risk of myocardial infarction in the general population. PLoS One. 2015;10(6):e0124653. http://dx.plos.org/10.1371/journal.pone.0124653.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    SAGES. Guidelines for Surgical Treatment of Gastroesophageal Reflux Disease (GERD) Limitations of the Available Literature. 2001. p. 1–22.Google Scholar
  39. 39.
    Jobe BA, Richter JE, Hoppo T, Peters JH, Bell R, Dengler WC, et al. Preoperative diagnostic workup before antireflux surgery: an evidence and experience-based consensus of the esophageal diagnostic advisory panel. J Am Coll Surg 2013;217(4):586–97. http://linkinghub.elsevier.com/retrieve/pii/S1072751513004249.PubMedCrossRefGoogle Scholar
  40. 40.
    Attwood SE, Lundell L, Ell C, Galmiche J-P, Hatlebakk J, Fiocca R, et al. Standardization of surgical technique in antireflux surgery: the LOTUS Trial experience. World J Surg. 2008;32(6):995–8. http://www.ncbi.nlm.nih.gov/pubmed/18224465. Accessed 2014 Dec 1PubMedCrossRefGoogle Scholar
  41. 41.
    Nissen R. [A simple operation for control of reflux esophagitis]. Schweiz Med Wochenschr. 1956;86(Suppl 20):590–2. http://www.ncbi.nlm.nih.gov/pubmed/13337262.PubMedGoogle Scholar
  42. 42.
    Kristo I, Schoppmann SF. Diagnosis and treatment of benign inflammatory esophageal diseases. Eur Surg. 2015;47(4):188–98. http://link.springer.com/10.1007/s10353-015-0329-5.CrossRefGoogle Scholar
  43. 43.
    DelGaudio JM. Direct nasopharyngeal reflux of gastric acid is a contributing factor in refractory chronic rhinosinusitis. Laryngoscope. 2005;115(6):946–57. http://www.ncbi.nlm.nih.gov/pubmed/15933499.PubMedCrossRefGoogle Scholar
  44. 44.
  45. 45.
    Meurman JH, Toskala J, Nuutinen P, Klemetti E. Oral and dental manifestations in gastroesophageal reflux disease. Oral Surg Oral Med Oral Pathol. 1994;78(5):583–9. http://www.ncbi.nlm.nih.gov/pubmed/7838463.PubMedCrossRefGoogle Scholar
  46. 46.
    Moazzez R, Bartlett D, Anggiansah A. Dental erosion, gastro-oesophageal reflux disease and saliva: how are they related? J Dent. 2004;32(6):489–94.PubMedCrossRefGoogle Scholar
  47. 47.
    Järvinen V, Meurman JH, Hyvärinen H, Rytömaa I, Murtomaa H. Dental erosion and upper gastrointestinal disorders. Oral Surgery. Oral Med Oral Pathol. 1988;65(3):298–303.CrossRefGoogle Scholar
  48. 48.
    Oginni AO, Agbakwuru EA, Ndububa DA. The prevalence of dental erosion in Nigerian patients with gastro-oesophageal reflux disease. BMC Oral Health. 2005;5(1):1. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=554987&tool=pmcentrez&rendertype=abstract.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Muñoz JV, Herreros B, Sanchiz V, Amoros C, Hernandez V, Pascual I, et al. Dental and periodontal lesions in patients with gastro-oesophageal reflux disease. Dig Liver Dis. 2003;35(7):461–7. http://www.ncbi.nlm.nih.gov/pubmed/12870730.PubMedCrossRefGoogle Scholar
  50. 50.
    Stovold R, Forrest IA, Corris PA, Murphy DM, Smith J, Decalmer S, et al. Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection. Am J Respir Crit Care Med. 2007;175(12):1298–303. http://www.ncbi.nlm.nih.gov/pubmed/17413126.PubMedCrossRefGoogle Scholar
  51. 51.
    Hartwig MG, Appel JZ, Duane Davis R. Antireflux surgery in the setting of lung transplantation: strategies for treating gastroesophageal reflux disease in a high-risk population. Thorac Surg Clin. 2005;15(3):417–27. http://linkinghub.elsevier.com/retrieve/pii/S1547412705000150.PubMedCrossRefGoogle Scholar
  52. 52.
    Cantu E, Appel JZ, Hartwig MG, Woreta H, Green C, Messier R, et al. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg. 2004;78(4):1142–51. http://linkinghub.elsevier.com/retrieve/pii/S0003497504009725.PubMedCrossRefGoogle Scholar
  53. 53.
    O’Halloran EK, Reynolds JD, Lau CL, Manson RJ, Davis RD, Palmer SM, et al. Laparoscopic Nissen fundoplication for treating reflux in lung transplant recipients. J Gastrointest Surg. 2004;8(1):132–7. http://www.ncbi.nlm.nih.gov/pubmed/14746846.PubMedCrossRefGoogle Scholar
  54. 54.
    Davis CS, Shankaran V, Kovacs EJ, Gagermeier J, Dilling D, Alex CG, et al. Gastroesophageal reflux disease after lung transplantation: pathophysiology and implications for treatment. Surgery 2010;148(4):737–45. http://linkinghub.elsevier.com/retrieve/pii/S0039606010003739.PubMedPubMedCentralCrossRefGoogle Scholar
  55. 55.
    Irwin RS. Chronic Cough Due to Gastroesophageal Reflux Disease: ACCP Evidence-Based Clinical Practice Guidelines. Chest. 2006;129(1_suppl):80S–94S.PubMedCrossRefGoogle Scholar
  56. 56.
    Ing A, Ngu M. Chronic persistent cough and gastro-oesophageal reflux Thorax. Concord; 1995. http://thorax.bmj.com/content/46/7/479.abstract.
  57. 57.
    Ing a J, Ngu MC. Cough and gastro-oesophageal reflux. Lancet. 1999;353(9157):944–6. http://www.ncbi.nlm.nih.gov/pubmed/10459900.PubMedCrossRefGoogle Scholar
  58. 58.
    Smith JA, Houghton LA. The oesophagus and cough: laryngo-pharyngeal reflux, microaspiration and vagal reflexes. Cough. 2013;9(1):12. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3640905&tool=pmcentrez&rendertype=abstract.PubMedPubMedCentralCrossRefGoogle Scholar
  59. 59.
    Hu X, Lee JS, Pianosi PT, Ryu JH, Aspiration-Related Pulmonary Syndromes. Chest J. 2015;147(3):815. http://www.ncbi.nlm.nih.gov/pubmed/25732447. Accessed 2015 Mar 20CrossRefGoogle Scholar
  60. 60.
    Ekström T, Johansson KE. Effects of anti-reflux surgery on chronic cough and asthma in patients with gastro-oesophageal reflux disease. Respir Med. 2000;94(12):1166–70.PubMedCrossRefGoogle Scholar
  61. 61.
    Komatsu Y, Hoppo T, Jobe B. Proximal reflux as a cause of adult-onset Asthma. JAMA Surg. 2013;148(1):50–8. http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Proximal+Reflux+as+a+Cause+of+Adult-Onset+Asthma#3. Accessed 2014 Feb 26PubMedCrossRefGoogle Scholar
  62. 62.
    Madanick RD. Extraesophageal presentations of GERD: where is the science? Gastroenterol Clin North Am. 2014;43(1):105–20. http://www.ncbi.nlm.nih.gov/pubmed/24503362. Accessed 2014 Dec 1PubMedCrossRefGoogle Scholar
  63. 63.
    Hoppo T, Jarido V, Pennathur A, Morrell M, Crespo M, Shigemura N, et al. Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg. 2011;146(9):1041–7. http://www.ncbi.nlm.nih.gov/pubmed/21931001.PubMedCrossRefGoogle Scholar
  64. 64.
    He Z, O’Reilly R, Bolling L, Soundar S, Shah M, Cook S, et al. Detection of gastric pepsin in middle ear fluid of children with otitis media. Otolaryngol - Head Neck Surg. 2007 137(1):59–64. http://oto.sagepub.com/lookup/doi/10.1016/j.otohns.2007.02.002.PubMedCrossRefGoogle Scholar
  65. 65.
    Qadeer MA, Colabianchi N, Strome M, Vaezi MF. Gastroesophageal reflux and laryngeal cancer: causation or association? A critical review. Am J Otolaryngol. 2006;27(2):119–28. http://linkinghub.elsevier.com/retrieve/pii/S0196070905001390.PubMedCrossRefGoogle Scholar
  66. 66.
    Ludemann JP, Manoukian J, Shaw K, Bernard C, Davis M, Al-Jubab A. Effects of simulated gastroesophageal reflux on the untraumatized rabbit larynx. J Otolaryngol. 1998;27(3):127–31.PubMedGoogle Scholar
  67. 67.
    Johnston N, Dettmar PW, Bishwokarma B, Lively MO, Koufman JA. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope. 2007;117:1036–9.PubMedCrossRefGoogle Scholar
  68. 68.
    Johnston N, Wells CW, Blumin JH, Toohill RJ, Merati AL. Receptor-mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol. 2007;116(12):934–8. http://www.ncbi.nlm.nih.gov/pubmed/18217514.PubMedCrossRefGoogle Scholar
  69. 69.
    Ing A, Ngu M, Breslin A. Chronic persistent cough and clearance of esophageal acid. Chest. 1992;102:1668–71. http://chestjournal.chestpubs.org/content/102/6/1668.short. Accessed 2013 Jan 8PubMedCrossRefGoogle Scholar
  70. 70.
    Fornari F, Blondeau K, Durand L, Rey E, Diaz-Rubio M, De Meyer A, et al. Relevance of mild ineffective oesophageal motility (IOM) and potential pharmacological reversibility of severe IOM in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2007;26(10):1345–54.PubMedCrossRefGoogle Scholar
  71. 71.
    Simrén M, Silny J, Holloway R, Tack J, Janssens J, Sifrim D. Relevance of ineffective oesophageal motility during oesophageal acid clearance. Intergovernmental panel on climate change. editor. Gut. Cambridge: Cambridge University Press; 2003;52(6):pp. 784–90.Google Scholar
  72. 72.
    Chen CL, Szczesniak MM, Cook IJ. Identification of impaired oesophageal bolus transit and clearance by secondary peristalsis in patients with non-obstructive dysphagia. Neurogastroenterol Motil. 2008;20(9):980–8.PubMedCrossRefGoogle Scholar
  73. 73.
    Knight RE, Wells JR, Parrish RS. Esophageal dysmotility as an Important co-factor in extraesophageal manifestations of Gastroesophageal Reflux. Laryngoscope. 2000;110(9):1462–6. http://doi.wiley.com/10.1097/00005537-200009000-00010.PubMedCrossRefGoogle Scholar
  74. 74.
    Fouad YM, Katz PO, Hatlebakk JG, Castell DO. Ineffective esophageal motility: the most common motility abnormality in patients with GERD-associated respiratory symptoms. Am J Gastroenterol. 1999;94(6):1464–7. http://www.ncbi.nlm.nih.gov/pubmed/10364008.PubMedCrossRefGoogle Scholar
  75. 75.
    Kastelik JA, Redington a E, Aziz I, Buckton GK, Smith CM, Dakkak M, et al. Abnormal oesophageal motility in patients with chronic cough. Thorax. 2003;58(8):699–702. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1746758&tool=pmcentrez&rendertype=abstract.PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Falk GL, Beattie J, Burton L, O’Donnell H, Falk MG, Van der Wall H, et al. Laryngopharyngeal reflux disease: correlation of reflux scintigraphy and 24 h impedance pH in a cohort of refractory symptomatic patients. Unpubl Work. 2015.Google Scholar
  77. 77.
    Ing A, Ngu M, Breslin A. Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Respir Crit Care Med. 1994;149:160–7. http://ajrccm.atsjournals.org/content/149/1/160.short. Accessed 2013 Jan 8.PubMedCrossRefGoogle Scholar
  78. 78.
    Javorkova N, Varechova S, Pecova R, Tatar M, Balaz D, Demeter M, et al. Acidification of the oesophagus acutely increases the cough sensitivity in patients with gastro-oesophageal reflux and chronic cough. Neurogastroenterol Motil. 2007;20(2):119–24. http://www.ncbi.nlm.nih.gov/pubmed/17999650. (071114170920003—???)PubMedGoogle Scholar
  79. 79.
    Collier BD. Detection of aspiration: scintigraphic techniques. Am J Med. 1997;103(5A):135S–137S. http://www.ncbi.nlm.nih.gov/pubmed/9422639.PubMedCrossRefGoogle Scholar
  80. 80.
    Falk GL, Beattie J, Ing A, Falk SE, Magee M, Burton L, et al. Scintigraphy in laryngopharyngeal and gastroesophageal reflux disease: a definitive diagnostic test? World J Gastroenterol. 2015;21(12):3619. http://www.wjgnet.com/1007–9327/full/v21/i12/3619.htm.PubMedPubMedCentralCrossRefGoogle Scholar
  81. 81.
    Morice AH, Fontana GA, Sovijarvi ARA, Pistolesi M, Chung KF, Widdicombe J, et al. The diagnosis and management of chronic cough. Eur Respir J. 2004. p. 481–92.Google Scholar
  82. 82.
    Irwin R, French C, Curley F, Zawacki J, Bennett F. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic, and pathogenetic aspects. Chest. 1993;104(5):1511–7.PubMedCrossRefGoogle Scholar
  83. 83.
    Pratter MR. Overview of Common Causes of Chronic Cough. Chest. 2006;129(1 Suppl):59S–62S.PubMedCrossRefGoogle Scholar
  84. 84.
    Qiu ZZ, Yu L, Xu S, Liu B, Zhao T, Lü H, et al. Cough reflex sensitivity and airway inflammation in patients with chronic cough due to non-acid gastro-oesophageal reflux. Respirology. 2011;16(4):645–52. http://www.ncbi.nlm.nih.gov/pubmed/21342332. Accessed 2012 Dec 13.PubMedCrossRefGoogle Scholar
  85. 85.
    Ziora D, Jarosz W, Dzielicki J, Ciekalski J, Krzywiecki A, Dworniczak S, et al. Citric acid cough threshold in patients with gastroesophageal reflux disease rises after laparoscopic fundoplication. Chest. 2005;2458–64.Google Scholar
  86. 86.
    Falk GL, Beattie J. Scintigraphy in laryngopharyngeal and gastroesophageal reflux disease: a definitive diagnostic test? World J Gastroenterol. 2015;21(12):3619. http://www.wjgnet.com/1007–9327/full/v21/i12/3619.htm.PubMedPubMedCentralCrossRefGoogle Scholar
  87. 87.
    Spechler S. Laryngopharyngeal reflux: a cause of faulty phonation or a faulted, phony diagnosis? Clin Gastroenterol Hepatol. 2006;4(4):431–2. http://www.cghjournal.org/article/S1542-3565(06)00079 – 6/abstract. Accessed 2013 Jan 8.PubMedCrossRefGoogle Scholar
  88. 88.
    Navaratnam RM, Winslet MC. Gastro-oesophageal reflux: the disease of the millennium. Hosp Med. 1998;59(8):646–9. http://www.ncbi.nlm.nih.gov/pubmed/9829061.PubMedGoogle Scholar
  89. 89.
    Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice. 2002;16(2):274–7.PubMedCrossRefGoogle Scholar
  90. 90.
    Habermann W, Schmid C, Neumann K, Devaney T, Hammer HF. Reflux symptom index and reflux finding score in otolaryngologic practice. J Voice. 2012;26(3):e123–7. http://dx.doi.org/10.1016/j.jvoice.2011.02.004.PubMedCrossRefGoogle Scholar
  91. 91.
    Ahmed TF, Khandwala F, Abelson TI, Hicks DM, Richter JE, Milstein C, et al. Chronic laryngitis associated with gastroesophageal reflux: prospective assessment of differences in practice patterns between gastroenterologists and ENT physicians. Am J Gastroenterol. 2006;101(3):470–8. http://www.ncbi.nlm.nih.gov/pubmed/16542282.PubMedCrossRefGoogle Scholar
  92. 92.
    Branski RC, Bhattacharyya N, Shapiro J. The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope. 2002;112(6):1019–24.PubMedCrossRefGoogle Scholar
  93. 93.
    Hicks DM, Ours TM, Abelson TI, Vaezi MF, Richter JE. The prevalence of hypopharynx findings associated with Gastroesophageal Reflux in normal volunteers. J Voice. 2002;16(4):564–79. http://linkinghub.elsevier.com/retrieve/pii/S0892199702001327.PubMedCrossRefGoogle Scholar
  94. 94.
    Milstein CF, Charbel S, Hicks DM, Abelson TI, Richter JE, Vaezi MF. Prevalence of laryngeal irritation signs associated with reflux in asymptomatic volunteers: impact of Endoscopic Technique (Rigid vs. Flexible Laryngoscope). Laryngoscope. 2005;115(12):2256–61. http://doi.wiley.com/10.1097/01.mlg.0000184325.44968.b1.PubMedCrossRefGoogle Scholar
  95. 95.
    Kelchner LN, Horne J, Lee L, Klaben B, Stemple JC, Adam S, et al. Reliability of speech-language pathologist and otolaryngologist ratings of laryngeal signs of reflux in an asymptomatic population using the reflux finding score. J Voice. 2007;21(1):92–100. http://www.ncbi.nlm.nih.gov/pubmed/16546351.PubMedCrossRefGoogle Scholar
  96. 96.
    Musser J, Kelchner L, Neils-Strunjas J, Montrose M. A comparison of rating scales used in the diagnosis of extraesophageal reflux. J Voice. 2011;25(3):293–300. http://www.ncbi.nlm.nih.gov/pubmed/20202786.PubMedCrossRefGoogle Scholar
  97. 97.
    de Bortoli N, Nacci A, Savarino E, Martinucci I, Bellini M, Fattori B, et al. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol. 2012;18(32):4363–70.PubMedPubMedCentralCrossRefGoogle Scholar
  98. 98.
    Vavricka SR, Storck CA, Wildi SM, Tutuian R, Wiegand N, Rousson V, et al. Limited diagnostic value of laryngopharyngeal lesions in patients with gastroesophageal reflux during routine upper gastrointestinal endoscopy. Am J Gastroenterol. 2007;102(4):716–22.PubMedCrossRefGoogle Scholar
  99. 99.
    Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope. 2001;111(8):1313–7.PubMedCrossRefGoogle Scholar
  100. 100.
    Garnett JD. Contact Granulomas. Medscape. 2015. http://emedicine.medscape.com/article/865924-overview.
  101. 101.
    Vaezi MF, Hicks DM, Abelson TI, Richter JE. Laryngeal signs and symptoms and gastroesophageal reflux disease (GERD): a critical assessment of cause and effect association. Clin Gastroenterol Hepatol. 2003;1(5):333–44.PubMedCrossRefGoogle Scholar
  102. 102.
    Koufman JA. The Otolaryngologic Manifestations of Gastroesophageal Reflux Disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal. Laryngoscope. 1991;101:1–77.PubMedCrossRefGoogle Scholar
  103. 103.
    Sifrim D, Dupont L, Blondeau K, Zhang X, Tack J, Janssens J. Weakly acidic reflux in patients with chronic unexplained cough during 24 h pressure, pH, and impedance monitoring. Gut. 2005;54(4):449–54. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1774432&tool=pmcentrez&rendertype=abstract. Accessed 2015 Jan 2.PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Zerbib F, Stoll D. Management of laryngopharyngeal reflux: an unmet medical need. Neurogastroenterol Motil. 2010;22(2):109–12.PubMedCrossRefGoogle Scholar
  105. 105.
    Ciecierega T, Gordon BL, Aronova A, Crawford CV, Zarnegar R. More Art than Science: impedance analysis prone to interpretation error. J Gastrointest Surg. 2015;19(6):987–92. http://link.springer.com/10.1007/s11605-015-2809-0.PubMedCrossRefGoogle Scholar
  106. 106.
    Zhou LY, Wang Y, Lu JJ, Lin L, Cui RL, Zhang HJ, et al. Accuracy of diagnosing gastroesophageal reflux disease by GerdQ, esophageal impedance monitoring and histology. J Dig Dis. 2014;15(5):230–8. http://www.ncbi.nlm.nih.gov/pubmed/24528678.PubMedCrossRefGoogle Scholar
  107. 107.
    Zerbib F, Roman S, Bruley Des Varannes S, Gourcerol G, Coffin B, Ropert A, et al. Normal Values of Pharyngeal and Esophageal 24-Hour pH Impedance in individuals on and off therapy and interobserver reproducibility. Clin Gastroenterol Hepatol. 2013;11(4):366–72. http://linkinghub.elsevier.com/retrieve/pii/S1542356512013092?showall=true. (W.B. Saunders for the American Gastroenterological Association)PubMedCrossRefGoogle Scholar
  108. 108.
    Hopkins C, Yousaf U, Pedersen M. Acid reflux treatment for hoarseness Cochrane Database Syst Rev. 2006. http://www.ncbi.nlm.nih.gov/pubmed/16437513.
  109. 109.
    Martinucci I, de Bortoli N, Savarino E, Nacci A, Romeo SO, Bellini M, et al. Optimal treatment of laryngopharyngeal reflux disease. Ther Adv Chronic Dis. 2013;4(6):287–301. http://taj.sagepub.com/cgi/doi/10.1177/2040622313503485.PubMedPubMedCentralCrossRefGoogle Scholar
  110. 110.
    Karkos PD, Wilson JA. Empiric treatment of laryngopharyngeal reflux with proton pump inhibitors: a systematic review. Laryngoscope. 2006;116:144–8.PubMedCrossRefGoogle Scholar
  111. 111.
    Qadeer MA, Phillips CO, Lopez AR, Steward DL, Noordzij JP, Wo JM, et al. Proton pump inhibitor therapy for suspected GERD-related chronic laryngitis: a meta-analysis of randomized controlled trials. Am J Gastroenterol. 2006;101(11):2646–54.PubMedCrossRefGoogle Scholar
  112. 112.
    Asaoka D, Nagahara A, Matsumoto K, Hojo M, Watanabe S. Current perspectives on reflux laryngitis. Clin J Gastroenterol. 2014;7(6):471–5. http://link.springer.com/10.1007/s12328-014-0535–x.PubMedCrossRefGoogle Scholar
  113. 113.
    Tasker A, Dettmar PW, Panetti M, Koufman JA, P Birchall J, Pearson JP. Is gastric reflux a cause of otitis media with effusion in children? Laryngoscope. 2002;112(11):1930–4. http://www.ncbi.nlm.nih.gov/pubmed/12439157.PubMedCrossRefGoogle Scholar
  114. 114.
    Lieu J, Muthappan P, Uppaluri R. Association of Reflux With Otitis Media in Children. Otolaryngol - Head Neck Surg. 2005;133(3):357–61. http://oto.sagepub.com/lookup/doi/10.1016/j.otohns.2005.05.654.PubMedCrossRefGoogle Scholar
  115. 115.
    Tasker A, Dettmar PW, Panetti M, Koufman JA, Birchall JP, Pearson JP. Reflux of gastric juice and glue ear in children. Lancet. 2002;359(9305):493. http://www.ncbi.nlm.nih.gov/pubmed/11853797.PubMedCrossRefGoogle Scholar
  116. 116.
    Dogru M, Kuran G, Haytoglu S, Dengiz R, Arikan OK, Role of Laryngopharyngeal Reflux in the Pathogenesis of Otitis Media with Effusion. J Int Adv Otol. 2015;11(1):66–71. http://www.advancedotology.org/eng/makale/823/87/Full-Text.PubMedCrossRefGoogle Scholar
  117. 117.
    Decalmer S, Stovold R, Houghton LA, Pearson J, Ward C, Kelsall A, et al. Chronic cough: relationship between microaspiration, gastroesophageal reflux, and cough frequency. Chest. 2012;142(4):958–64.PubMedCrossRefGoogle Scholar
  118. 118.
    Grabowski M, Kasran A, Seys S, Pauwels A, Medrala W, Dupont L, et al. Pepsin and bile acids in induced sputum of chronic cough patients. Respir Med. 2011;105(8):1257–61. http://www.sciencedirect.com/science/article/pii/S0954611111001612.PubMedCrossRefGoogle Scholar
  119. 119.
    Pauwels A. Bile acids in Sputum and increased airway inflammation in patients with Cystic Fibrosis. Chest J. 2012;141(6):1568. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=22135379.CrossRefGoogle Scholar
  120. 120.
    Iqbal M, Batch AJ, Spychal RT, Cooper BT. Outcome of surgical fundoplication for extraesophageal (atypical) manifestations of gastroesophageal reflux disease in adults: a systematic review. J Laparoendosc Adv Surg Tech A. 2008;18(6):789–96. http://www.ncbi.nlm.nih.gov/pubmed/19105666. Accessed 2014 Jan 31.PubMedCrossRefGoogle Scholar
  121. 121.
    Bardhan KD, Strugala V, Dettmar PW. Reflux Revisited: advancing the role of pepsin. Int J Otolaryngol. 2012;2012:1–13. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3216344&tool=pmcentrez&rendertype=abstract.CrossRefGoogle Scholar
  122. 122.
    Samuels T, Johnston N. Pepsin as a marker of extraesophageal reflux. Ann Otol Rhinol Laryngo. 2010;119(3):203–8.Google Scholar
  123. 123.
    Noordzij JP, Khidr A, Desper E, Meek RB, Reibel JF, Levine PA. Correlation of pH probe-measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope. 2002;112(12):2192–5. http://www.ncbi.nlm.nih.gov/pubmed/12461340. Accessed 2015 Jan 2.PubMedCrossRefGoogle Scholar
  124. 124.
    Vaezi M, Schroeder P, Richter J. Reproducibility of proximal probe pH parameters in 24-hour ambulatory esophageal pH monitoring. Am J Gastroenterol. 1997;92:825–9. http://europepmc.org/abstract/MED/9149194. Accessed 2015 Jan 4PubMedGoogle Scholar
  125. 125.
    Kawamura O, Aslam M, Rittmann T, Hofmann C, Shaker R. Physical and pH properties of gastroesophagopharyngeal refluxate: a 24-hour simultaneous ambulatory impedance and pH monitoring study. Am J Gastroenterol. 2004;99(6):1000–10. http://www.ncbi.nlm.nih.gov/pubmed/15180717. Accessed 2015 Jan 4.PubMedCrossRefGoogle Scholar
  126. 126.
    Merati A, Lim H, Ulualp S, Toohill R. Meta-analysis of upper probe measurements in normal subjects and patients with laryngopharyngeal reflux. Ann Otol Rhinol Laryngol. 2005;114:177–82. http://w.annals.com/toc/auto_article_process.php?year=2005&page=177&id=14155&sn=0. Accessed 2015 Jan 2.PubMedCrossRefGoogle Scholar
  127. 127.
    Sun G, Muddana S, Slaughter JC, Casey S, Hill E, Farrokhi F, et al. A new pH catheter for laryngopharyngeal reflux: normal values. Laryngoscope. 2009;119(8):1639–43. http://doi.wiley.com/10.1002/lary.20282.PubMedCrossRefGoogle Scholar
  128. 128.
    Sasaki C, Marotta J, Hundal J, Chow J, Eisen R. Bile-induced laryngitis: is there a basis in evidence? Ann Otol Rhinol Laryngol. 2005;114:192–7.PubMedCrossRefGoogle Scholar
  129. 129.
    Divi V, Benninger MS. Diagnosis and management of laryngopharyngeal reflux disease. Curr Opin Otolaryngol Head Neck Surg. 2006;14(3):124–7. http://www.ncbi.nlm.nih.gov/pubmed/16728886.
  130. 130.
    Vela MFMF, Camacho-Lobato L, Srinivasan R, Tutuian R, Katz PO, Castell DO. Simultaneous intraesophageal impedance and pH measurement of acid and nonacid gastroesophageal reflux: effect of omeprazole. Gastroenterology. 2001;120(7):1599–606. http://linkinghub.elsevier.com/retrieve/pii/S0016508501428782. Accessed 2013 Feb 5.PubMedCrossRefGoogle Scholar
  131. 131.
    Saritas Yuksel E, Vaezi MF. New developments in extraesophageal reflux disease. Gastroenterol Hepatol (N Y). 2012;8(9):590–9. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3594960&tool=pmcentrez&rendertype=abstract.Google Scholar
  132. 132.
    Maurer AH, Parkman HP. Update on Gastrointestinal Scintigraphy. Semin Nucl Med. 2006;36(2):110–8. http://linkinghub.elsevier.com/retrieve/pii/S0001299805000723.PubMedCrossRefGoogle Scholar
  133. 133.
    Kjellén G, Brudin L, Håkansson HO. Is scintigraphy of value in the diagnosis of gastrooesophageal reflux disease? Scand J Gastroenterol. 1991;26(4):425–30. http://www.ncbi.nlm.nih.gov/pubmed/2034995.PubMedCrossRefGoogle Scholar
  134. 134.
    Russell C. Functional evaluation of the esophagus. In: Hill L, editor. The Esophagus Medical and surgical management. Philadelphia: WB Saunders; 1988. p. 45.Google Scholar
  135. 135.
    Shay SS, Abreu SH, Tsuchida A. Scintigraphy in gastroesophageal reflux disease: a comparison to endoscopy, LESp, and 24-h pH score, as well as to simultaneous pH monitoring. Am J Gastroenterol. 1992;87(9):1094–101. http://www.ncbi.nlm.nih.gov/pubmed/1519565.PubMedGoogle Scholar
  136. 136.
    Thomas EJ, Kumar R, Dasan JB, Kabra SK, Bal CS, Menon S, et al. Gastroesophageal reflux in asthmatic children not responding to asthma medication: a scintigraphic study in 126 patients with correlation between scintigraphic and clinical findings of reflux. Clin Imaging. 2003;27(5):333–6. http://www.ncbi.nlm.nih.gov/pubmed/12932685.PubMedCrossRefGoogle Scholar
  137. 137.
    Ravelli AM. Pulmonary Aspiration Shown by Scintigraphy in Gastroesophageal Reflux-Related Respiratory Disease. Chest J. 2006;130(5):1520. http://journal.publications.chestnet.org/article.aspx?doi=10.1378/chest.130.5.1520.CrossRefGoogle Scholar
  138. 138.
    Ruth M, Carlsson S, Månsson I, Bengtsson U, Sandberg N. Scintigraphic detection of gastro-pulmonary aspiration in patients with respiratory disorders. Clin Physiol. 1993;13(1):19–33. http://www.ncbi.nlm.nih.gov/pubmed/8382143.PubMedCrossRefGoogle Scholar
  139. 139.
    Falk M, Van der Wall H, Falk GL. Differences between scintigraphic reflux studies in gastrointestinal reflux disease and laryngopharyngeal reflux disease and correlation with symptoms. Nucl Med Commun. 2015;36(6):625–30. http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00006231-900000000–99055. Accessed 2015 Mar 20PubMedCrossRefGoogle Scholar
  140. 140.
    Bestetti A, Carola F, Carnevali-Ricci P, Sambataro G, Tarolo GL. 99mTc-sulfur colloid gastroesophageal scintigraphy with late lung imaging to evaluate patients with posterior laryngitis. J Nucl Med. 2000;41(10):1597–602. http://www.ncbi.nlm.nih.gov/pubmed/11037986.PubMedGoogle Scholar
  141. 141.
    Pearson J, Parikh S, Orlando R, Johnston N, Allen J, Tinling S, et al. Review article: reflux and its consequences - the laryngeal, pulmonary and oesophageal manifestations. Aliment Pharmacol Ther. 2011;33(Suppl 1):1–71. http://doi.wiley.com/10.1111/j.1365–2036.2011.04581.x.PubMedCrossRefGoogle Scholar
  142. 142.
    Anderson JW, Jhaveri MA. Reductions in medications with substantial weight loss with behavioral intervention. Curr Clin Pharmacol. 2010;5(4):232–8.PubMedCrossRefGoogle Scholar
  143. 143.
    Fraser-Moodie CA, Norton B, Gornall C, Magnago S, Weale a R, Holmes GK. Weight loss has an independent beneficial effect on symptoms of gastro-oesophageal reflux in patients who are overweight. Scand J Gastroenterol. 1999;34(4):337–40.PubMedCrossRefGoogle Scholar
  144. 144.
    Reimer C, Bytzer P. Management of laryngopharyngeal reflux with proton pump inhibitors. Ther Clin Risk Manag. 2008;4(1):225–33.PubMedPubMedCentralGoogle Scholar
  145. 145.
    Fackler WK, Ours TM, Vaezi MF, Richter JE. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology. 2002;122(3):625–32. http://linkinghub.elsevier.com/retrieve/pii/S0016508502694454\n http://www.ncbi.nlm.nih.gov/pubmed/11874994.PubMedCrossRefGoogle Scholar
  146. 146.
    Ours TM, Keith Fackler W, Richter JE, Vaezi MF. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol. 2003;98(3):545–50.PubMedCrossRefGoogle Scholar
  147. 147.
    Boeckxstaens GE, Beaumont H, Mertens V, Denison H, Ruth M, Adler J, et al. Effects of lesogaberan on reflux and lower esophageal sphincter function in patients with gastroesophageal reflux disease. Gastroenterology. 2010;139(2):409–17. http://www.ncbi.nlm.nih.gov/pubmed/20451523.PubMedCrossRefGoogle Scholar
  148. 148.
    Cossentino MJ, Mann K, Armbruster SP, Lake JM, Maydonovitch C, Wong RKH. Randomised clinical trial: the effect of baclofen in patients with gastro-oesophageal reflux—a randomised prospective study. Aliment Pharmacol Ther. 2012;35:1036–44. http://www.ncbi.nlm.nih.gov/pubmed/22428773.PubMedGoogle Scholar
  149. 149.
    Ciccaglione AF, Marzio L. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 h pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut. 2003;52(4):464–70. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1773602&tool=pmcentrez&rendertype=abstract.PubMedPubMedCentralCrossRefGoogle Scholar
  150. 150.
    Shaheen NJ, Denison H, Bjorck K, Karlsson M, Silberg DG. Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial. Gut. 2013;62(9):1248–55. http://gut.bmj.com/cgi/doi/10.1136/gutjnl-2012-302737.PubMedCrossRefGoogle Scholar
  151. 151.
    Kelsall A, Houghton LA, Jones H, Decalmer S, McGuinness K, Smith JA. A novel approach to studying the relationship between subjective and objective measures of cough. Chest. 2011;139(3):569–75. http://www.ncbi.nlm.nih.gov/pubmed/20864619.PubMedCrossRefGoogle Scholar
  152. 152.
    Dicpinigaitis PV, Rauf K. Treatment of chronic, refractory cough with baclofen. Respiration. 1998;65(1):86–8.PubMedCrossRefGoogle Scholar
  153. 153.
    Xu X. Successful resolution of refractory chronic cough induced by gastroesophageal reflux with treatment of baclofen. Chest J. 2012;142(4_MeetingAbstracts):16 A. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3500706&tool=pmcentrez&rendertype=abstract.CrossRefGoogle Scholar
  154. 154.
    Lidums I, Lehmann A, Checklin H, Dent JHR. Control of transient lower esophageal sphincter relaxations and reflux by the GABA(B) agonist baclofen in normal subjects. Gastroenterology. 2000;118(1):7–13.PubMedCrossRefGoogle Scholar
  155. 155.
    Dicpinigaitis P, Dobkin J, Rauf K, Aldrich T. Inhibition of capsaicin- induced cough by the gamma-aminobutyric acid agonist baclofen. J Clin Pharmacol. 1998;38:364–7.PubMedCrossRefGoogle Scholar
  156. 156.
    Glicksman JT, Mick PT, Fung K, Carroll TL. Prokinetic agents and laryngopharyngeal reflux disease: prokinetic agents and laryngopharyngeal reflux disease: a systematic review. Laryngoscope. 2014;124(10):2375–9. http://doi.wiley.com/10.1002/lary.24738.PubMedCrossRefGoogle Scholar
  157. 157.
    Pavesi L, Subburaj S, Porter-Shaw K. Application and validation of a computerized cough acquisition system for objective monitoring of acute cough: a meta-analysis. Chest. 2001;120(4):1121–8.PubMedCrossRefGoogle Scholar
  158. 158.
    Young E, Sumner H, Decalmer S, Houghton L, Woodcock A, Smith J. Does central up-regulation of the n-methyl-d-aspartate receptor contribute to cough reflex hypersensitivity? Am J Respir Crit Care Med. 2010;181(Meeting Abstracts):A5906.Google Scholar
  159. 159.
    Morice AH, Menon MS, Mulrennan SA, Everett CF, Wright C, Jackson J, et al. Opiate therapy in chronic cough. Am J Respir Crit Care Med. 2007;175(4):312–5. http://www.ncbi.nlm.nih.gov/pubmed/17122382.PubMedCrossRefGoogle Scholar
  160. 160.
    Mintz S, Lee JK. Gabapentin in the treatment of intractable idiopathic chronic cough: case reports. Am J Med. 2006;119(5):e13–5. http://www.ncbi.nlm.nih.gov/pubmed/16651037.PubMedCrossRefGoogle Scholar
  161. 161.
    Broekaert D, Fischler B, Sifrim D, Janssens J, Tack J. Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2006;23(3):365–70. http://www.ncbi.nlm.nih.gov/pubmed/16422995.PubMedCrossRefGoogle Scholar
  162. 162.
    Viazis N, Keyoglou A, Kanellopoulos AK, Karamanolis G, Vlachogiannakos J, Triantafyllou K, et al. Selective Serotonin Reuptake inhibitors for the treatment of Hypersensitive Esophagus: A Randomized, Double-Blind, Placebo-Controlled Study. Am J Gastroenterol. 2012;107(11):1662–7. http://www.nature.com/doifinder/10.1038/ajg.2011.179.PubMedCrossRefGoogle Scholar
  163. 163.
    Mainie I, Tutuian R, Agrawal A. Combined multichannel intraluminal impedance–pH monitoring to select patients with persistent gastro‐oesophageal reflux for laparoscopic Nissen fundoplication. Br J Surg. 2006;93(12):1483–7. http://onlinelibrary.wiley.com/doi/10.1002/bjs.5493/full. Accessed 2015 Jan 5.PubMedCrossRefGoogle Scholar
  164. 164.
    Novitsky YW, Zawacki JK, Irwin RS, French CT, Hussey VM, Callery MP. Chronic cough due to gastroesophageal reflux disease: efficacy of antireflux surgery. Surg Endosc. 2002;16(4):567–71. http://www.ncbi.nlm.nih.gov/pubmed/11972189. Accessed 2015 Jan 5.PubMedCrossRefGoogle Scholar
  165. 165.
    Patti MG, Arcerito M, Tamburini A, Diener U, Feo CV, Safadi B, et al. Effect of laparoscopic fundoplication on gastroesophageal reflux disease-induced respiratory symptoms. J Gastrointest Surg. 1999;4(2):143–9. http://www.ncbi.nlm.nih.gov/pubmed/10675237.CrossRefGoogle Scholar
  166. 166.
    Greason KL, Miller DL, Deschamps C, Allen MS, Nichols FC, Trastek VF, et al. Effects of antireflux procedures on respiratory symptoms. Ann Thorac Surg. 2002;73(2):381–5.PubMedCrossRefGoogle Scholar
  167. 167.
    Brouwer R, Kiroff GK. Improvement of respiratory symptoms following laparoscopic Nissen fundoplication. ANZ J Surg. 2003;73(4):189–93.PubMedCrossRefGoogle Scholar
  168. 168.
    Oelschlager BK, Eubanks TR, Oleynikov D, Pope C, Pellegrini CA. Symptomatic and physiologic outcomes after operative treatment for extraesophageal reflux. Surg Endosc. 2002;16(7):1032–6. http://www.ncbi.nlm.nih.gov/pubmed/11984664. Accessed 2013 Feb 27.PubMedCrossRefGoogle Scholar
  169. 169.
    Spivak H, Smith CD, Phichith A, Galloway K, Waring JP, Hunter JG. Asthma and gastroesophageal reflux: fundoplication decreases need for systemic corticosteroids. J Gastrointest Surg. 1999;3(5):477–82.PubMedCrossRefGoogle Scholar
  170. 170.
    Allen CJ, Anvari M. Gastro-oesophageal reflux related cough and its response to laparoscopic fundoplication. Thorax. 1998;53(11):963–8. http://thorax.bmj.com/cgi/doi/10.1136/thx.53.11.963.PubMedPubMedCentralCrossRefGoogle Scholar
  171. 171.
    Wright RC, Rhodes KP, Improvement of laryngopharyngeal reflux symptoms after laparoscopic Hill repair. Am J Surg. 2003;185(5):455–61. http://www.sciencedirect.com/science/article/pii/S0002961003000527. Accessed 2015 Jan 7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2016

Authors and Affiliations

  1. 1.University of SydneySydneyAustralia
  2. 2.Macquarie UniversitySydneyAustralia
  3. 3.LindfieldAustralia
  4. 4.Sydney Heartburn ClinicLindfieldAustralia

Personalised recommendations